ATAI’s Chief Scientific Officer addresses the future of psychiatric drug development at ISAD19

Last week, Srinivas Rao, Chief Scientific Officer of ATAI Life Sciences, spoke at the 10th Conference of the International Society for Affective Disorders (ISAD19), an important gathering of the European affective disorders expert community. This year’s programme addressed fundamental, clinical and translational issues in affective disorders, with experts from around the world travelling to London […]